Hangzhou Biotest Biotech Co.,Ltd.

¥36.80As of Sun 8 Nov 2026, 12:00 UTC
SSE:688767Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR 1.87%
Div yield 1.90%
ROE 0.40%
Biotechnology
Beta (5Y) 0.73
PE TTM 496.4
TSR TTM (19.57%)
Mkt cap ¥5.385B
ROIC 1.56%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥42
13.05%
(77.71%)
Hold 1|7|3|4|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.77
0.74
0.76
0.83
17.28%
5.81%
(2.95%)
8.10%
Revenue¥M
277.4
276.3
290.8
288.4
0.08%
(1.47%)
3.87%
1.97%
Peers (US$807.2M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.104
(0.482)
(0.414)
EBIT/Intx
1.424
0.128
0.133
Own earn%
27.79
(9.01)
(17.77)
Sh yield%
10.83
27.38
28.41
Owners
Insiders/Inst%
4.44
45.48
Short interest%
3.25
SBC / revenue%
4.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
11–24
$1 testx
—
Incr. ROIC%
4